RVNC has not (yet) issued a PR confirming FDA's acceptance of the sBLA (for review), but that doesn't imply RVNC is getting an RTF letter. RVNC could simply be waiting until January to issue a PR containing not only the PDUFA date, but also some 2023 guidance (as many biotech companies do at the start of a new year).
An RTF is conceivable but is quite unlikely, IMO.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.